Skip to main content
Questions about giving or our research? Call us — (800) 321-2873 Donor help Search

by
Blog, Cancer-Fighting Lifestyle
February 22, 2022

[vc_row][vc_column][vc_single_image image="47610" img_size="full" alignment="center"][/vc_column][/vc_row][vc_row][vc_column][vc_column_text]Getting the body moving can be particularly challenging during winter when many parts of the country are under an icy blanket of snow. Undoubtedly, it is more comfortable to stay snuggled up on the couch, dreaming of spring. However, new research shows that physical...

, ,

by
Blog
September 20, 2021

[vc_row][vc_column][vc_single_image image="44750" img_size="full" alignment="center"][vc_column_text]Immune checkpoint inhibitor (ICI) drugs, such as the PD-1inhibitors nivolumab and pembrolizumab, have provided unprecedented survival to patients in many types of cancer in recent years and are used for late-stage cancer treatment worldwide. Unfortunately, many patients who responded well to initial treatments gradually...

, , , ,

by
Blog
June 9, 2021

[vc_row][vc_column][vc_single_image image="43279" img_size="full" alignment="center"][/vc_column][/vc_row][vc_row][vc_column][vc_column_text]Exercise plays an important role in preventing a variety of cancers. A recent study has increased the importance of maintaining a well-balanced and active lifestyle, indicating a positive outlook for many breast cancer patients.  National Foundation for Cancer Research (NFCR)-funded scientist Dr. Rakesh Jain, and his team...

, ,

by
Blog
January 21, 2021

[vc_row][vc_column][vc_single_image image="40075" img_size="full" alignment="center" css=""][/vc_column][/vc_row][vc_row][vc_column][vc_column_text css=""]Immuno-oncology (IO) drugs have demonstrated unprecedented benefits in the treatment of several types of cancer. The overall survival time of cancer patients treated by IO drugs have been dramatically extended, and in some cases, even late stage fatal cancers are...

, ,

by
Blog, Coronavirus
January 21, 2021

[vc_row][vc_column][vc_single_image image="40066" img_size="full" alignment="center" css=""][/vc_column][/vc_row][vc_row][vc_column][vc_column_text css=""] New publication by NFCR-supported scientist Rakesh Jain, Ph.D., applies cancer research findings to help COVID-19 treatment in different patient groups. Few drugs for COVID-19 appear to work well in unselected patients, but now a new mathematical model provides insight into...

, ,

by
Blog
December 15, 2020

[vc_row][vc_column][vc_column_text css=""] New approach developed by Dr. Rakesh Jain and his research team identifies biomarkers that may indicate which patients will best respond to immune checkpoint blockade therapies. A research team led by NFCR-supported scientist Rakesh K. Jain, PhD, the Andrew Werk Cook Professor of Tumor Biology...

, , ,

by
Blog
March 19, 2020

[vc_row][vc_column][vc_column_text] Researchers at the University of Cardiff discovered that MR1-restricted T-cells can be used to broaden both the types of cancer and patients that can be treated using cellular therapy. During the past decade, cancer immunotherapy has emerged, along with surgery, radiation, and chemotherapy, as a fourth,...

, ,